Company: XTIA
Filing Date: 2025-09-12
Form Type: 424B5
Source: 0001213900-25-087270
Chunk: 16

Company: XTI Aerospace, Inc.
Filing Date: 2025-09-12
Form: 424B5
Chunk 16
---
holder approval rule. We cannot assure you that Nasdaq will determine that this offering will be deemed a Public Offering under the stockholder approval rule. If Nasdaq determines that this offering was not conducted in compliance with the stockholder approval rule, Nasdaq may cite a deficiency and move to delist our common stock from The Nasdaq Capital Market. Upon a delisting from The Nasdaq Capital Market, our stock would likely be traded in the over-the-counter inter-dealer quotation system, more commonly known as the OTC. OTC transactions involve risks in addition to those associated with transactions in securities traded on the securities exchanges, such as The Nasdaq Capital Market, or, together, Exchange-listed stocks. Many OTC stocks trade less frequently and in smaller volumes than Exchange-listed stocks. Accordingly, our stock would be less liquid than it would be otherwise. Also, the prices of OTC stocks are often more volatile than Exchange-listed stocks. Additionally, institutional investors are usually prohibited from investing in OTC stocks, and it might be more challenging to raise capital when needed.

<div align='center'>S-5</div>

This offering may cause the trading price of our common stock to decrease.

The number of shares of common stock and/or Pre-funded Warrants or
the Common Warrants and the underlying shares of common stock we propose to issue and ultimately will issue if this offering is completed,
may result in an immediate decrease in the trading price of our common stock. This decrease may continue after the completion of this
offering. We cannot predict the effect, if any, that the availability of shares for future sale represented by the Pre-funded Warrants
or the Common Warrants issued in connection with the offering will have on the trading price of our common stock from time to time.

Our stock price is volatile, and your investment may suffer a decline in value.

The closing market price
for our common stock has varied between a high of $60.45 on September 17, 2024, and a low of $1.04 on April 1, 2025, in the twelve-month
period ended September 11, 2025. During this time, the price per share of common stock has ranged from an intra-day low of $0.96 per
share to an intra-day high of $62.50 per share. As a result of fluctuations in the price of our common stock, you may be unable to sell
your shares at or above the price you paid for them. The market price of